Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

The lawsuit argues that new federal rules went beyond what Congress enacted and broke from guidance that the federal government previewed to states.

Last week, I introduced Emmy Noether, an extraordinary figure in the fields of mathematics and physics. To understand Noether ...

Yes, and he would say it without hesitation. At 52 with $280,000 saved, you are within 10 to 15 years of a retirement ...

Oregon’s landmark effort allowing adults older than 21 to access psilocybin has evolved beyond “strictly medical uses” and ...

You might think of Google Drive as just cloud storage, but it can do much more than manage files. Here are some of the other ...

Here’s something most digital PR agencies won’t tell you upfront: the metrics they highlight in their monthly reports are not ...

Wealth Enhancement reports that business owners should focus on five key metrics—EBITDA, cash flow, customer concentration, owner dependency, and after-tax proceeds—before selling.

I wasn't getting the full benefits of my sun protection ...

GDP quarterly national accounts show people grew worse off in January to March 2026, and saved less too ...

You know that feeling when you walk into a room and immediately forget why you came in? Maybe you were there to fetch your ...

Splatoon has always featured single-player campaigns, but they’ve never been the focus. Often they’re glorified tutorials, ...